Of these, UGGT1 (UDP-glucose glycoprotein glucosyltransferase) was selected for further investigation because the A-to-I editing of its transcripts is associated with increased expression levels, which, according to the literature, correlates with poor prognosis in cancer patients [16,17,18]. Here, UGGT1 is linked to cancer.